What to watch in the biomedical space over the next five years

The pandemic has brought the spotlight onto the healthcare and biomedical sectors, driving unprecedented enthusiasm in the relatively unknown field of mRNA innovations, and bolstering growth in digital health. Yet, the silver lining has dulled investors’ sentiments post-COVID. Increasingly, investors have become more cautious against macroeconomic headwinds, and many are expecting a correction in company valuations across all sectors.

Our Inaugural Sustainability Report 2021/2022

Investing in a resilient and sustainable future EDBI Sustainability Report 2021/2022 Recognising the importance of how investors play an influential role in encouraging sustainability, EDBI is doing our part to contribute to Singapore’s commitments towards a more sustainable world. Our inaugural sustainability report charts our role as a strategic investor and outlines our ESG practices …

Our Inaugural Sustainability Report 2021/2022 Read More »